Preferred Name | Parecoxib Sodium | |
Synonyms |
PARECOXIB SODIUM Propanamide, N-((4-(5-methyl-3-phenyl-4- isoxazolyl)phenyl)sulfonyl)-, Sodium Salt Parecoxib Sodium Dynastat |
|
Definitions |
A water-soluble, injectable sodium salt form of parecoxib, an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73831 |
|
CAS_Registry |
197502-82-2 198470-85-8 |
|
Chemical_Formula |
C19H17N2O4S.Na |
|
code |
C73831 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A water-soluble, injectable sodium salt form of parecoxib, an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation. |
|
FDA_UNII_Code |
EB87433V6F |
|
FULL_SYN |
PARECOXIB SODIUM Propanamide, N-((4-(5-methyl-3-phenyl-4- isoxazolyl)phenyl)sulfonyl)-, Sodium Salt Parecoxib Sodium Dynastat |
|
label |
Parecoxib Sodium |
|
Legacy Concept Name |
Parecoxib_Sodium |
|
NCI_Drug_Dictionary_ID |
753381 |
|
PDQ_Closed_Trial_Search_ID |
753381 |
|
PDQ_Open_Trial_Search_ID |
753381 |
|
Preferred_Name |
Parecoxib Sodium |
|
prefixIRI |
Thesaurus:C73831 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0915144 |
|
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/RXNORM/279951 | RXNORM | LOOM | |
http://purl.bioontology.org/ontology/PDQ/CDR0000753381 | PDQ | LOOM | |
http://sbmi.uth.tmc.edu/ontology/ochv#C0915144 | OCHV | LOOM | |
http://purl.obolibrary.org/obo/NCIT_C73831 | BERO | LOOM | |
http://purl.bioontology.org/ontology/SNOMEDCT/734520005 | SNOMEDCT | LOOM |